RADIANT: A Study of Tarceva After Surgery With or Without Adjuvant Chemotherapy in NSCLC Patients Who Have EGFR-positive Tumors - No Study Results Posted

RADIANT: A Study of Tarceva After Surgery With or Without Adjuvant Chemotherapy in NSCLC Patients Who Have EGFR-positive Tumors (Adjuvent)

This study is currently recruiting participants.

Study NCT00373425 Information provided by OSI Pharmaceuticals

First Received: September 7, 2006 Last Updated: November 3, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	September 2013
Estimated Primary Completion Date:	September 2009 (Final data collection date for primary outcome measure)